ManRos Therapeutics' compounds are currently being investigated in three areas of therapeutics, at various development stages.

All compound families of second generation kinase inhibitors currently developed by ManRos Therapeutics are protected by international patent applications, all filed recently. Novel patents covering products, processes and indications are currently being filed to further protect and extend our intellectual property.